The tau-PET tracer 18F-AV-1451 showed uniquely higher retention in the hippocampus of MAPT rs242557 risk variant carriers who are more likely to develop tau pathology, implying its potential specific binding property for AD-like tau pathology. The gene discussed is MAPT; the disease is Alzheimer disease.